Publications

Bellail AC, Olson JJ and Hao C:  SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.  Nature Communications, June 23, 2014, 5:4234 | DOI: 10.1038/ncomms5234. 

Wang L, Chen D, Yang X, Olson JJ, Gopinath K, et al. Group Independent Component Analysis and Functional MRI Examination of Changes in Language Areas Associated with Brain Tumors at Different Locations. PLoS ONE 8(3): e59657. doi:10.1371/journal.pone.0059657, 2013.

Yin S. Kaluz S. Devi NS. Jabbar AA. de Noronha RG. Mun J. Zhang Z. Boreddy PR. Wang W. Wang Z. Abbruscato T. Chen Z. Olson JJ. Zhang R. Goodman MM. Nicolaou KC. Van Meir EG:  Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1 interaction with cofactors p300/CBP.  Clinical Cancer Research. 18(24):6623-33, 2012.

Wei L. Hong S. Yoon Y. Hwang SN. Park JC. Zhang Z. Olson JJ. Hu XP. Shim H:  Early prediction of response to Vorinostat in an orthotopic rat glioma model.  NMR in Biomedicine. 25(9):1104-11, 2012.

Zheng Z. Ng WL. Zhang X. Olson JJ. Hao C. Curran WJ. Wang Y:  RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells.  Cancer Research. 72(5):1221-8, 2012. 

Qi Q. He K. Yoo MH. Chan CB. Liu X. Zhang Z. Olson JJ. Xiao G. Wang L. Mao H. Fu H. Tao H. Ramalingam SS. Sun SY. Mischel PS. Ye K:  Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases.  Journal of Biological Chemistry. 287(9):6113-27, 2012. 

Wei F, Liu Y, Bellail AC, Olson JJ, Sun SY, Lu G, Ding L, Changji Yuan C, Wang G, Hao C:  K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas. Cancer Letters 322: 58-69, 2012

Zheng Z, Ng WL, Zhang X, Olson JJ, Hao C, Curran WJ, Wang Y:  RNAi-mediated targeting of non-coding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells. ,Canc Bellail AC, Olson JJ, Yang X, Chen ZJ, Hao C:  A-20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.  Cancer Discovery 2: 140-155, 2012.  er Research. 72: 1221-8, 2012

Qi L, Bellail AC,  Rossi MR, Zhang Z, Pang H, Hunter S, Cohen C, Moreno CS, Olson JJ, Li S, Hao C:  Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis.  Apoptosis 16:  1150-1164, 2011.

Ding L, Yuan C, Wei F, Wang G, Zhang J, Bellail AC, Zhang Z, Olson JJ, Hao C:  Cisplatin Restores TRAIL Apoptotic Pathway in Glioblastoma-Derived Stem Cells through Up-regulation of DR5 and Down-regulation of c-FLIP. Cancer Invest 29: 511-520, 2011.

Yan D., Ng WL., Zhang X, Wang P, Zhang Z, Mo YY, Mao H, Hao C, Olson JJ, Curran WJ, Wang Y:  Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation.  PLoS ONE 5 (e11397):  1-8, 2010.

Bellail AC, Tse MCL, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C:  DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.  J. Cell. Mol. Med 14: 1303-17, 2010.